Cargando…

Recurrent thrombosis after carotid endarterectomy secondary to activated protein C resistance and essential thrombocytosis: A case report

RATIONALE: Thrombosis is a major cause of morbidity in the perioperative period. Although many risk factors are known, activated protein C resistance is a prominent risk for thrombosis. Activated protein C resistance frequently occurs with recurrent thromboembolism. PATIENT CONCERNS: A 59-year-old K...

Descripción completa

Detalles Bibliográficos
Autores principales: Huh, In Young, Han, Il Sang, Lee, Hyung Kwan, Shin, Yong Joon, Lee, Jae Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221756/
https://www.ncbi.nlm.nih.gov/pubmed/30383703
http://dx.doi.org/10.1097/MD.0000000000013118
_version_ 1783369084956573696
author Huh, In Young
Han, Il Sang
Lee, Hyung Kwan
Shin, Yong Joon
Lee, Jae Min
author_facet Huh, In Young
Han, Il Sang
Lee, Hyung Kwan
Shin, Yong Joon
Lee, Jae Min
author_sort Huh, In Young
collection PubMed
description RATIONALE: Thrombosis is a major cause of morbidity in the perioperative period. Although many risk factors are known, activated protein C resistance is a prominent risk for thrombosis. Activated protein C resistance frequently occurs with recurrent thromboembolism. PATIENT CONCERNS: A 59-year-old Korean woman patient with hypertension was admitted due to dysarthria and left side motor weakness. DIAGNOSIS AND INTERVENTIONS: Magnetic resonance imaging showed subacute cerebral infarction with right frontoparietal lobe and stenosis at the right internal carotid artery. She underwent right carotid endarterectomy under general anesthesia. However, recurrent thrombosis on postoperative day 1 was noted at patient's right carotid artery, which prompted emergency surgery. Additional preoperative laboratory review revealed findings for activated protein C resistance, low protein S activity, antinuclear antibody (>1:160), anti-cardiolipin IgM antibody (16.6), and thrombocytosis, Janus kinase and factor V Leiden mutations. At the intensive care unit, heparin was continually infused until postoperative day 12 and was then switched to warfarin. OUTCOMES: Patient was discharged at postoperative day 21 without any event. Patient had no signs of recurrence within the 3-year follow-up period, and she is still on oral warfarin and clopidogrel. LESSONS: Screening test for hypercoagulability can be used to identify patients at higher risk of postoperative complications. If hypercoagulability state is confirmed by laboratory testing, a suitable anticoagulant treatment plan should be made within the perioperative period.
format Online
Article
Text
id pubmed-6221756
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-62217562018-12-04 Recurrent thrombosis after carotid endarterectomy secondary to activated protein C resistance and essential thrombocytosis: A case report Huh, In Young Han, Il Sang Lee, Hyung Kwan Shin, Yong Joon Lee, Jae Min Medicine (Baltimore) Research Article RATIONALE: Thrombosis is a major cause of morbidity in the perioperative period. Although many risk factors are known, activated protein C resistance is a prominent risk for thrombosis. Activated protein C resistance frequently occurs with recurrent thromboembolism. PATIENT CONCERNS: A 59-year-old Korean woman patient with hypertension was admitted due to dysarthria and left side motor weakness. DIAGNOSIS AND INTERVENTIONS: Magnetic resonance imaging showed subacute cerebral infarction with right frontoparietal lobe and stenosis at the right internal carotid artery. She underwent right carotid endarterectomy under general anesthesia. However, recurrent thrombosis on postoperative day 1 was noted at patient's right carotid artery, which prompted emergency surgery. Additional preoperative laboratory review revealed findings for activated protein C resistance, low protein S activity, antinuclear antibody (>1:160), anti-cardiolipin IgM antibody (16.6), and thrombocytosis, Janus kinase and factor V Leiden mutations. At the intensive care unit, heparin was continually infused until postoperative day 12 and was then switched to warfarin. OUTCOMES: Patient was discharged at postoperative day 21 without any event. Patient had no signs of recurrence within the 3-year follow-up period, and she is still on oral warfarin and clopidogrel. LESSONS: Screening test for hypercoagulability can be used to identify patients at higher risk of postoperative complications. If hypercoagulability state is confirmed by laboratory testing, a suitable anticoagulant treatment plan should be made within the perioperative period. Wolters Kluwer Health 2018-11-02 /pmc/articles/PMC6221756/ /pubmed/30383703 http://dx.doi.org/10.1097/MD.0000000000013118 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Research Article
Huh, In Young
Han, Il Sang
Lee, Hyung Kwan
Shin, Yong Joon
Lee, Jae Min
Recurrent thrombosis after carotid endarterectomy secondary to activated protein C resistance and essential thrombocytosis: A case report
title Recurrent thrombosis after carotid endarterectomy secondary to activated protein C resistance and essential thrombocytosis: A case report
title_full Recurrent thrombosis after carotid endarterectomy secondary to activated protein C resistance and essential thrombocytosis: A case report
title_fullStr Recurrent thrombosis after carotid endarterectomy secondary to activated protein C resistance and essential thrombocytosis: A case report
title_full_unstemmed Recurrent thrombosis after carotid endarterectomy secondary to activated protein C resistance and essential thrombocytosis: A case report
title_short Recurrent thrombosis after carotid endarterectomy secondary to activated protein C resistance and essential thrombocytosis: A case report
title_sort recurrent thrombosis after carotid endarterectomy secondary to activated protein c resistance and essential thrombocytosis: a case report
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221756/
https://www.ncbi.nlm.nih.gov/pubmed/30383703
http://dx.doi.org/10.1097/MD.0000000000013118
work_keys_str_mv AT huhinyoung recurrentthrombosisaftercarotidendarterectomysecondarytoactivatedproteincresistanceandessentialthrombocytosisacasereport
AT hanilsang recurrentthrombosisaftercarotidendarterectomysecondarytoactivatedproteincresistanceandessentialthrombocytosisacasereport
AT leehyungkwan recurrentthrombosisaftercarotidendarterectomysecondarytoactivatedproteincresistanceandessentialthrombocytosisacasereport
AT shinyongjoon recurrentthrombosisaftercarotidendarterectomysecondarytoactivatedproteincresistanceandessentialthrombocytosisacasereport
AT leejaemin recurrentthrombosisaftercarotidendarterectomysecondarytoactivatedproteincresistanceandessentialthrombocytosisacasereport